Celebrating a job well done by Ernest Graypel, MD, MHA, Brandon Lenfest, Mejra Dzinic, and our St. Louis team! After joining an Alzheimer’s trial as a rescue site, the team exceeded its enrollment goal. Thank you for the hard work behind this accomplishment!
Tekton Research, a multi-specialty clinical research site organization, has hired three vice presidents to lead its neuroscience, cardiometabolic, and endocrinology research operations, and to advance its patient engagement strategy. All three began their careers working inside research sites. Patricia Brown, PhD, APRN, joins as Vice President, Clinical Operations, Neuroscience. Brown has worked on both the … Read more
Tekton has introduced the Tekton Psychiatry Team, bringing together physician-investigators and operational leaders to provide centralized expertise for mental and behavioral health studies across 17 Tekton sites. From protocol review and rater consistency to participant engagement and staff mentorship, the team strengthens how Tekton sites support mood, anxiety, addiction, and behavioral health research. The Psychiatry Team … Read more
Tekton Research’s San Antonio, TX, and Edmond, OK, teams achieved 300% of their combined initial enrollment goal for a recent Phase 2 obesity trial, randomizing 60 participants against a target of 20. Congratulations to: Jara McDonald, MD, FAAFP, DABOM, CPI, Evelyn Guajardo, and our San Antonio team Kyle Rickner, MD, Bettina Beard, and our Edmond … Read more
Tekton Research is proud to congratulate Marlee Sanchez, Clinical Research Coordinator III in Fort Collins, CO, on being named a finalist for the first-ever SCRS Next Up Award. Marlee brings care and a collaborative spirit to her work, guiding participants through complex studies, mentoring colleagues, and helping Tekton’s sites across Colorado and beyond work as … Read more
Brian Bailey, MSBS-MS, is Tekton’s Clinical Compliance and Operations Director, based in Austin, Texas. He oversees site-level investigational product (IP) management and helps set compliance and operations processes companywide. We spoke with him about his Navy and surgical background, improving temperature-alert response across Tekton, and what Sponsors and CROs can do to make IP management … Read more
Tekton is expanding to Houston, TX, with the addition of Lawrence D. Ginsberg, MD. Dr. Ginsberg will lead adult and pediatric psychiatry studies as a Principal Investigator from his clinic, Red Oak Psychiatry Associates. This marks Tekton’s first research location in Houston. Dr. Ginsberg has practiced psychiatry since 1985 and has served as president and … Read more
Andrew H. Martin, MD, psychiatrist and founder of Texas Family Psychiatry, will expand Tekton’s psychiatry research capabilities in San Antonio. Tekton is pleased to welcome Andrew H. Martin, MD, as a Principal Investigator at its San Antonio dedicated research center. Dr. Martin is a psychiatrist with more than 20 years of clinical experience treating children, … Read more
Tekton’s Austin, TX, team screened the first participant globally for Boehringer Ingelheim’s Phase 3 study evaluating nerandomilast for systemic sclerosis. Congratulations to Paul Pickrell, MD, and our entire Austin team on this milestone!
Pablo Mora, MD, is the lead author of two new articles published in The Lancet. The articles report Phase 2 results for zenagamtide, a novel unimolecular GLP-1 and amylin receptor agonist being studied in adults with type 2 diabetes. Across cohorts, both once-weekly subcutaneous and once-daily oral formulations produced substantial improvements in glycemic control and … Read more